Structure

Physi-Chem Properties

Molecular Weight:  510.17
Volume:  479.098
LogP:  0.404
LogD:  -0.222
LogS:  -2.68
# Rotatable Bonds:  7
TPSA:  195.6
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.173
Synthetic Accessibility Score:  4.946
Fsp3:  0.542
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.379
MDCK Permeability:  5.626748315989971e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.953
Human Intestinal Absorption (HIA):  0.48
20% Bioavailability (F20%):  0.876
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.149
Plasma Protein Binding (PPB):  68.65837860107422%
Volume Distribution (VD):  0.389
Pgp-substrate:  29.894760131835938%

ADMET: Metabolism

CYP1A2-inhibitor:  0.017
CYP1A2-substrate:  0.081
CYP2C19-inhibitor:  0.019
CYP2C19-substrate:  0.067
CYP2C9-inhibitor:  0.008
CYP2C9-substrate:  0.11
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.123
CYP3A4-inhibitor:  0.203
CYP3A4-substrate:  0.064

ADMET: Excretion

Clearance (CL):  1.155
Half-life (T1/2):  0.764

ADMET: Toxicity

hERG Blockers:  0.049
Human Hepatotoxicity (H-HT):  0.192
Drug-inuced Liver Injury (DILI):  0.027
AMES Toxicity:  0.069
Rat Oral Acute Toxicity:  0.393
Maximum Recommended Daily Dose:  0.361
Skin Sensitization:  0.606
Carcinogencity:  0.884
Eye Corrosion:  0.003
Eye Irritation:  0.02
Respiratory Toxicity:  0.975

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC49597

Natural Product ID:  NPC49597
Common Name*:   8-Coumaroylharpagide
IUPAC Name:   [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:   8-Coumaroylharpagide
Standard InCHIKey:  AZKQDXZMKREFDY-CBLWINFVSA-N
Standard InCHI:  InChI=1S/C24H30O12/c1-23(36-16(28)7-4-12-2-5-13(26)6-3-12)10-15(27)24(32)8-9-33-22(20(23)24)35-21-19(31)18(30)17(29)14(11-25)34-21/h2-9,14-15,17-22,25-27,29-32H,10-11H2,1H3/b7-4+/t14-,15-,17-,18+,19-,20-,21+,22+,23+,24-/m1/s1
SMILES:  OC[C@H]1O[C@@H](O[C@@H]2OC=C[C@@]3([C@H]2[C@@](C)(OC(=O)/C=C/c2ccc(cc2)O)C[C@H]3O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL513852
PubChem CID:   10324058
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5565 Harpagophytum procumbens Species Pedaliaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO5565 Harpagophytum procumbens Species Pedaliaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5565 Harpagophytum procumbens Species Pedaliaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2688 Organism Sus scrofa Sus scrofa Inhibition < 50.0 % PMID[503818]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC49597 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9701 High Similarity NPC46644
0.9559 High Similarity NPC263397
0.9559 High Similarity NPC302286
0.9559 High Similarity NPC88754
0.9559 High Similarity NPC116104
0.9559 High Similarity NPC237872
0.9489 High Similarity NPC184464
0.9489 High Similarity NPC251062
0.9412 High Similarity NPC137501
0.9412 High Similarity NPC7518
0.9412 High Similarity NPC154262
0.9412 High Similarity NPC159387
0.9353 High Similarity NPC37838
0.9348 High Similarity NPC478240
0.9318 High Similarity NPC254819
0.9286 High Similarity NPC18789
0.9275 High Similarity NPC186296
0.9155 High Similarity NPC478234
0.9091 High Similarity NPC240592
0.9091 High Similarity NPC117346
0.9091 High Similarity NPC147224
0.9084 High Similarity NPC267733
0.9084 High Similarity NPC276047
0.9034 High Similarity NPC229548
0.9034 High Similarity NPC478241
0.9034 High Similarity NPC89693
0.903 High Similarity NPC475824
0.9028 High Similarity NPC269914
0.9028 High Similarity NPC478249
0.9021 High Similarity NPC478236
0.9021 High Similarity NPC96599
0.8986 High Similarity NPC31745
0.8986 High Similarity NPC220936
0.8966 High Similarity NPC194705
0.8951 High Similarity NPC308178
0.8936 High Similarity NPC202391
0.8936 High Similarity NPC296659
0.8931 High Similarity NPC145287
0.8897 High Similarity NPC289021
0.8897 High Similarity NPC158546
0.8872 High Similarity NPC106677
0.8851 High Similarity NPC475378
0.8797 High Similarity NPC471157
0.8797 High Similarity NPC252114
0.8779 High Similarity NPC52097
0.875 High Similarity NPC478255
0.8741 High Similarity NPC253595
0.8732 High Similarity NPC293154
0.8731 High Similarity NPC156692
0.8731 High Similarity NPC35288
0.8731 High Similarity NPC175333
0.8731 High Similarity NPC471882
0.8731 High Similarity NPC173150
0.8731 High Similarity NPC45224
0.8731 High Similarity NPC471881
0.8731 High Similarity NPC288416
0.8725 High Similarity NPC478248
0.8722 High Similarity NPC83218
0.8722 High Similarity NPC126991
0.8716 High Similarity NPC478232
0.8705 High Similarity NPC472132
0.8702 High Similarity NPC11724
0.8696 High Similarity NPC169398
0.8675 High Similarity NPC478265
0.8671 High Similarity NPC77922
0.8671 High Similarity NPC473281
0.8667 High Similarity NPC225307
0.8658 High Similarity NPC475484
0.8657 High Similarity NPC61181
0.8649 High Similarity NPC229354
0.8639 High Similarity NPC475379
0.8626 High Similarity NPC476872
0.8613 High Similarity NPC225384
0.8613 High Similarity NPC138777
0.8613 High Similarity NPC246869
0.8613 High Similarity NPC235294
0.8613 High Similarity NPC46137
0.8601 High Similarity NPC475213
0.8601 High Similarity NPC152796
0.8593 High Similarity NPC103533
0.8581 High Similarity NPC478235
0.8553 High Similarity NPC138993
0.8552 High Similarity NPC474268
0.8552 High Similarity NPC143246
0.8552 High Similarity NPC475539
0.8552 High Similarity NPC474234
0.8552 High Similarity NPC119773
0.8542 High Similarity NPC63304
0.8511 High Similarity NPC101686
0.8511 High Similarity NPC469364
0.8511 High Similarity NPC65262
0.8493 Intermediate Similarity NPC473149
0.8489 Intermediate Similarity NPC254398
0.8483 Intermediate Similarity NPC475528
0.8478 Intermediate Similarity NPC281798
0.8467 Intermediate Similarity NPC295970
0.8442 Intermediate Similarity NPC476011
0.8417 Intermediate Similarity NPC473924
0.8417 Intermediate Similarity NPC473285
0.8397 Intermediate Similarity NPC301910
0.8397 Intermediate Similarity NPC130730
0.8369 Intermediate Similarity NPC263829
0.8369 Intermediate Similarity NPC476870
0.8366 Intermediate Similarity NPC179914
0.8357 Intermediate Similarity NPC28637
0.8355 Intermediate Similarity NPC478266
0.8345 Intermediate Similarity NPC219677
0.8333 Intermediate Similarity NPC477293
0.8333 Intermediate Similarity NPC229784
0.8333 Intermediate Similarity NPC477294
0.8323 Intermediate Similarity NPC206815
0.8322 Intermediate Similarity NPC69367
0.8322 Intermediate Similarity NPC321184
0.8322 Intermediate Similarity NPC35097
0.8322 Intermediate Similarity NPC328273
0.8322 Intermediate Similarity NPC321638
0.8322 Intermediate Similarity NPC171134
0.8312 Intermediate Similarity NPC474936
0.831 Intermediate Similarity NPC166180
0.8299 Intermediate Similarity NPC473147
0.8298 Intermediate Similarity NPC34293
0.8298 Intermediate Similarity NPC287597
0.8298 Intermediate Similarity NPC471883
0.8298 Intermediate Similarity NPC886
0.8288 Intermediate Similarity NPC194938
0.8278 Intermediate Similarity NPC469699
0.8276 Intermediate Similarity NPC296643
0.8269 Intermediate Similarity NPC109990
0.8267 Intermediate Similarity NPC474620
0.8261 Intermediate Similarity NPC232880
0.8252 Intermediate Similarity NPC476376
0.8228 Intermediate Similarity NPC208818
0.8227 Intermediate Similarity NPC470143
0.8227 Intermediate Similarity NPC322503
0.8219 Intermediate Similarity NPC204644
0.8212 Intermediate Similarity NPC203664
0.8209 Intermediate Similarity NPC476448
0.8209 Intermediate Similarity NPC476445
0.8209 Intermediate Similarity NPC469548
0.8207 Intermediate Similarity NPC215512
0.8207 Intermediate Similarity NPC476442
0.8205 Intermediate Similarity NPC145847
0.8194 Intermediate Similarity NPC89105
0.8194 Intermediate Similarity NPC472350
0.8194 Intermediate Similarity NPC476383
0.8194 Intermediate Similarity NPC68092
0.8194 Intermediate Similarity NPC197316
0.8194 Intermediate Similarity NPC81515
0.8194 Intermediate Similarity NPC226005
0.8194 Intermediate Similarity NPC64141
0.8194 Intermediate Similarity NPC269668
0.8188 Intermediate Similarity NPC120728
0.8188 Intermediate Similarity NPC189631
0.8188 Intermediate Similarity NPC476873
0.8182 Intermediate Similarity NPC157554
0.8182 Intermediate Similarity NPC471345
0.8182 Intermediate Similarity NPC329997
0.8176 Intermediate Similarity NPC212808
0.8163 Intermediate Similarity NPC110063
0.8163 Intermediate Similarity NPC196063
0.8163 Intermediate Similarity NPC296954
0.8163 Intermediate Similarity NPC300894
0.8163 Intermediate Similarity NPC141455
0.8158 Intermediate Similarity NPC257847
0.8151 Intermediate Similarity NPC140502
0.8146 Intermediate Similarity NPC77310
0.8134 Intermediate Similarity NPC282409
0.8134 Intermediate Similarity NPC469702
0.8133 Intermediate Similarity NPC161955
0.8129 Intermediate Similarity NPC146540
0.8125 Intermediate Similarity NPC78363
0.8125 Intermediate Similarity NPC260425
0.8121 Intermediate Similarity NPC97240
0.8106 Intermediate Similarity NPC175771
0.8106 Intermediate Similarity NPC148055
0.8099 Intermediate Similarity NPC114116
0.8095 Intermediate Similarity NPC478250
0.8095 Intermediate Similarity NPC478239
0.8095 Intermediate Similarity NPC40305
0.8095 Intermediate Similarity NPC105005
0.8092 Intermediate Similarity NPC313193
0.8082 Intermediate Similarity NPC476385
0.8082 Intermediate Similarity NPC186406
0.8082 Intermediate Similarity NPC476377
0.8082 Intermediate Similarity NPC134405
0.8082 Intermediate Similarity NPC47471
0.8077 Intermediate Similarity NPC208676
0.8077 Intermediate Similarity NPC130489
0.8071 Intermediate Similarity NPC469549
0.8069 Intermediate Similarity NPC220942
0.8069 Intermediate Similarity NPC100389
0.8069 Intermediate Similarity NPC205195
0.8067 Intermediate Similarity NPC169510
0.8065 Intermediate Similarity NPC187205
0.8063 Intermediate Similarity NPC21956
0.8056 Intermediate Similarity NPC103409
0.8056 Intermediate Similarity NPC37468
0.8056 Intermediate Similarity NPC470572
0.8054 Intermediate Similarity NPC320734
0.8054 Intermediate Similarity NPC229505

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC49597 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8194 Intermediate Similarity NPD7266 Discontinued
0.8137 Intermediate Similarity NPD7685 Pre-registration
0.7662 Intermediate Similarity NPD1653 Approved
0.75 Intermediate Similarity NPD1091 Approved
0.7315 Intermediate Similarity NPD6653 Approved
0.7292 Intermediate Similarity NPD3094 Phase 2
0.7273 Intermediate Similarity NPD6190 Approved
0.7178 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1652 Phase 2
0.7133 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5124 Phase 1
0.7124 Intermediate Similarity NPD5762 Approved
0.7124 Intermediate Similarity NPD5763 Approved
0.7123 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.708 Intermediate Similarity NPD969 Suspended
0.7055 Intermediate Similarity NPD6362 Approved
0.7039 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7097 Phase 1
0.7037 Intermediate Similarity NPD1358 Approved
0.7014 Intermediate Similarity NPD3092 Approved
0.7013 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD6005 Phase 3
0.7013 Intermediate Similarity NPD6004 Phase 3
0.7013 Intermediate Similarity NPD6002 Phase 3
0.7011 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7007 Intermediate Similarity NPD5647 Approved
0.6994 Remote Similarity NPD8455 Phase 2
0.6987 Remote Similarity NPD4628 Phase 3
0.6972 Remote Similarity NPD9545 Approved
0.6963 Remote Similarity NPD3134 Approved
0.6959 Remote Similarity NPD2861 Phase 2
0.6959 Remote Similarity NPD5736 Approved
0.6954 Remote Similarity NPD4140 Approved
0.6946 Remote Similarity NPD7199 Phase 2
0.6941 Remote Similarity NPD7228 Approved
0.6933 Remote Similarity NPD37 Approved
0.6928 Remote Similarity NPD6234 Discontinued
0.6909 Remote Similarity NPD4967 Phase 2
0.6909 Remote Similarity NPD4965 Approved
0.6909 Remote Similarity NPD4966 Approved
0.6908 Remote Similarity NPD4340 Discontinued
0.6899 Remote Similarity NPD5058 Phase 3
0.6897 Remote Similarity NPD422 Phase 1
0.6883 Remote Similarity NPD7033 Discontinued
0.6879 Remote Similarity NPD6559 Discontinued
0.6875 Remote Similarity NPD5126 Approved
0.6875 Remote Similarity NPD5125 Phase 3
0.6855 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6842 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6842 Remote Similarity NPD3818 Discontinued
0.6821 Remote Similarity NPD3764 Approved
0.681 Remote Similarity NPD4380 Phase 2
0.6802 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6802 Remote Similarity NPD7054 Approved
0.6797 Remote Similarity NPD5735 Approved
0.6797 Remote Similarity NPD6355 Discontinued
0.6781 Remote Similarity NPD3705 Approved
0.6776 Remote Similarity NPD6663 Approved
0.6776 Remote Similarity NPD6233 Phase 2
0.6765 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6763 Remote Similarity NPD7472 Approved
0.6755 Remote Similarity NPD3027 Phase 3
0.6746 Remote Similarity NPD8127 Discontinued
0.6744 Remote Similarity NPD7799 Discontinued
0.6743 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6736 Remote Similarity NPD3091 Approved
0.6732 Remote Similarity NPD3620 Phase 2
0.6732 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6732 Remote Similarity NPD4060 Phase 1
0.6724 Remote Similarity NPD6797 Phase 2
0.6709 Remote Similarity NPD6674 Discontinued
0.6707 Remote Similarity NPD7028 Phase 2
0.6705 Remote Similarity NPD8313 Approved
0.6705 Remote Similarity NPD8312 Approved
0.669 Remote Similarity NPD1357 Approved
0.6689 Remote Similarity NPD4908 Phase 1
0.6688 Remote Similarity NPD230 Phase 1
0.6686 Remote Similarity NPD7251 Discontinued
0.6667 Remote Similarity NPD6273 Approved
0.6667 Remote Similarity NPD7074 Phase 3
0.6667 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7075 Discontinued
0.6667 Remote Similarity NPD7843 Approved
0.6648 Remote Similarity NPD7808 Phase 3
0.6646 Remote Similarity NPD2424 Discontinued
0.6643 Remote Similarity NPD7157 Approved
0.663 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6627 Remote Similarity NPD6801 Discontinued
0.6626 Remote Similarity NPD5403 Approved
0.6623 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6623 Remote Similarity NPD1613 Approved
0.6621 Remote Similarity NPD7741 Discontinued
0.6619 Remote Similarity NPD2684 Approved
0.6618 Remote Similarity NPD5738 Clinical (unspecified phase)
0.6607 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6601 Remote Similarity NPD6798 Discontinued
0.6601 Remote Similarity NPD4907 Clinical (unspecified phase)
0.66 Remote Similarity NPD2797 Approved
0.6597 Remote Similarity NPD694 Clinical (unspecified phase)
0.6594 Remote Similarity NPD6685 Approved
0.6591 Remote Similarity NPD7240 Approved
0.6577 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6575 Remote Similarity NPD7503 Approved
0.6564 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6562 Remote Similarity NPD8166 Discontinued
0.6562 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6554 Remote Similarity NPD1610 Phase 2
0.6547 Remote Similarity NPD290 Approved
0.6545 Remote Similarity NPD7458 Discontinued
0.6536 Remote Similarity NPD7095 Approved
0.6533 Remote Similarity NPD3225 Approved
0.6531 Remote Similarity NPD3095 Discontinued
0.6524 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6507 Remote Similarity NPD1548 Phase 1
0.6503 Remote Similarity NPD5401 Approved
0.6503 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6503 Remote Similarity NPD7004 Clinical (unspecified phase)
0.65 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6497 Remote Similarity NPD4538 Approved
0.6497 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6497 Remote Similarity NPD4536 Approved
0.6494 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6494 Remote Similarity NPD3268 Approved
0.6488 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6486 Remote Similarity NPD3496 Discontinued
0.646 Remote Similarity NPD3750 Approved
0.6456 Remote Similarity NPD5588 Approved
0.6452 Remote Similarity NPD4062 Phase 3
0.645 Remote Similarity NPD5402 Approved
0.6447 Remote Similarity NPD4624 Approved
0.6442 Remote Similarity NPD6799 Approved
0.6438 Remote Similarity NPD970 Clinical (unspecified phase)
0.6434 Remote Similarity NPD5535 Approved
0.6433 Remote Similarity NPD6353 Approved
0.6424 Remote Similarity NPD8651 Approved
0.6419 Remote Similarity NPD4626 Approved
0.6419 Remote Similarity NPD4059 Approved
0.6414 Remote Similarity NPD4198 Discontinued
0.6402 Remote Similarity NPD3536 Discontinued
0.6398 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6397 Remote Similarity NPD3020 Approved
0.6387 Remote Similarity NPD6410 Clinical (unspecified phase)
0.638 Remote Similarity NPD7236 Approved
0.6377 Remote Similarity NPD6647 Phase 2
0.6377 Remote Similarity NPD5765 Approved
0.637 Remote Similarity NPD9493 Approved
0.6369 Remote Similarity NPD1933 Approved
0.6369 Remote Similarity NPD7411 Suspended
0.6364 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6364 Remote Similarity NPD3751 Discontinued
0.6364 Remote Similarity NPD6912 Phase 3
0.6358 Remote Similarity NPD4110 Phase 3
0.6358 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6358 Remote Similarity NPD5327 Phase 3
0.6358 Remote Similarity NPD4749 Approved
0.6358 Remote Similarity NPD3685 Discontinued
0.6353 Remote Similarity NPD3817 Phase 2
0.6352 Remote Similarity NPD4108 Discontinued
0.6352 Remote Similarity NPD5960 Phase 3
0.6351 Remote Similarity NPD5691 Approved
0.6345 Remote Similarity NPD690 Clinical (unspecified phase)
0.6343 Remote Similarity NPD2934 Approved
0.6343 Remote Similarity NPD2933 Approved
0.6338 Remote Similarity NPD3021 Approved
0.6338 Remote Similarity NPD3022 Approved
0.6335 Remote Similarity NPD1549 Phase 2
0.6335 Remote Similarity NPD5958 Discontinued
0.6331 Remote Similarity NPD1934 Approved
0.6328 Remote Similarity NPD5844 Phase 1
0.6323 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6312 Remote Similarity NPD2935 Discontinued
0.6312 Remote Similarity NPD9265 Clinical (unspecified phase)
0.631 Remote Similarity NPD6599 Discontinued
0.6309 Remote Similarity NPD5238 Clinical (unspecified phase)
0.6299 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6296 Remote Similarity NPD2859 Approved
0.6296 Remote Similarity NPD2860 Approved
0.6294 Remote Similarity NPD5761 Phase 2
0.6294 Remote Similarity NPD7930 Approved
0.6294 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6294 Remote Similarity NPD5760 Phase 2
0.6294 Remote Similarity NPD7819 Suspended
0.6287 Remote Similarity NPD7239 Suspended
0.6286 Remote Similarity NPD9697 Approved
0.6283 Remote Similarity NPD7435 Discontinued
0.6283 Remote Similarity NPD7497 Discontinued
0.6278 Remote Similarity NPD7549 Discontinued
0.6275 Remote Similarity NPD987 Approved
0.6273 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6273 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6272 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6267 Remote Similarity NPD3847 Discontinued
0.6258 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6257 Remote Similarity NPD2415 Discontinued
0.6257 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6257 Remote Similarity NPD8443 Clinical (unspecified phase)
0.625 Remote Similarity NPD8397 Clinical (unspecified phase)
0.625 Remote Similarity NPD6167 Clinical (unspecified phase)
0.625 Remote Similarity NPD6166 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data